What's Going On With Tilray Brands Stock? The Blunt Truth

Tilray Brands, Inc. TLRY shares are trading lower Monday. Kerrisdale Capital issued a short report on the company. Here's a look at what's going on.

What To Know:

Kerrisdale Capital stated that it is short shares of Tilray and released a report titled, "The Blunt Truth."

Kerrisdale Capital's report claims that Tilray's cash flow and other financial metrics are skewed due to the payment of debts with shares of stock instead of cash which has led to dilution of value for shareholders.

The report also stated that Tilray investors have overreacted to the recent marijuana rescheduling developments because Tilray is a Canadian company that would not benefit from a change in U.S. regulations, though its Americans competitors would.

Kerrisdale Capital gave a price target of 89 cents for TLRY shares, representing a downside potential of 70%.

TLRY Price Action: According to Benzinga Pro, Tilray Brands shares are down nearly 6% at $2.77 at the time of publication.

Image: Eugenio Cuppone from Pixabay

Market News and Data brought to you by Benzinga APIs

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

The Benzinga Cannabis Capital Conference is coming to Florida